Drugs

Agennix AG to Participate in 6th Annual International Partnering Conference BIO-Europe Spring(R) 2012

PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX: PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX -- (Marketwire) -- 03/19/12 -- Agennix AG (FRANKFURT: AGX) (XETRA: AGX) today announced that the Company will participate in th ...

Novo Energies Corporation Announces the Appointment of Immunovative Therapies, Ltd.'s GCP and GMP Experts

NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 03/15/12 -- Novo Energies Corporation ("Novo") (OTCBB: NVNC) today announced that Immunovative Therapies, Ltd. ("Immunovative") has retained the s ...

Flamel Technologies Announces Projected Release Date of Fourth Quarter and Year-End 2011 Results; Additional Releases; Conference Call

LYON, FRANCE: LYON, FRANCE -- (Marketwire) -- 03/13/12 -- (NASDAQ: FLML) expects to release its financial results for the fourth quarter and the fiscal year 2011, as well as additional releases, on Wednesday, Mar ...

Advent Financial Initiates a Positive Coverage on Nouveau Life Pharmaceuticals, Inc. (PINKSHEETS: HRID)

NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 03/13/12 -- Advent Financial is pleased to announce that it has initiated positive research coverage on Nouveau Life Pharmaceuticals, Inc. (PINKSHEETS: HRID).To view ...

Sirona Biochem Inducer Produces More Protein than Commercial Leader in Study

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 03/12/12 -- Sirona Biochem Corp. (TSX VENTURE: SBM)(PINKSHEETS: SRBCF)(FRANKFURT: ZSB) announced results of a study with its biological inducer in the e ...

Ardea Biosciences Reports Recent Accomplishments and Announces Fourth Quarter and Full-Year 2011 Financial Results

SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwire) -- 03/09/12 -- Ardea Biosciences, Inc. (NASDAQ: RDEA), a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious dis ...

Pivotal Therapeutics Inc. Information to be Available through S&P Capital IQ's Market Access Program

WOODBRIDGE, ONTARIO: WOODBRIDGE, ONTARIO -- (Marketwire) -- 03/08/12 -- Pivotal Therapeutics Inc. (CNSX: PVO), announced today that its company information will be made available via S&P Capital IQ's Market Acc ...

Prana Doses First Patient in the "IMAGINE" Phase II Alzheimer's Disease Trial

MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwire) -- 03/07/12 -- (NASDAQ: PRAN) (ASX: PBT) today announced that the first patient has been dosed in the "IMAGINE Trial" -- 12 month Phase II Imaging tria ...

Horizon Pharma Enters Into Exclusive Agreement With Mundipharma for Commercialization of LODOTRA(R) (Modified-Release Prednisone) in Latin America

DEERFIELD, IL: DEERFIELD, IL -- (Marketwire) -- 03/07/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP), a biopharmaceutical company developing and commercializing innovative medicines to target unmet therapeutic needs in ...

Cytokinetics Announces That the European Medicines Agency Has Granted CK-2017357 Orphan Medicinal Product Designation for the Treatment of Amyotrophic Lateral Sclerosis

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 03/06/12 -- Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that the European Medicines Agency (EMA) has granted the company's fast skeletal ...